![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kensey Nash Corp. (MM) | NASDAQ:KNSY | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 38.45 | 0 | 01:00:00 |
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Bollinger Report screened and selected AngioDynamics, Inc. for its current position within the healthcare industry. AngioDynamics, Inc. (AngioDynamics) is a provider of medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease (PVD) and local oncology therapy options for treating cancer, including radiofrequency ablation (RFA) systems, embolization products for treating benign and malignant tumors and surgical resection systems, including NanoKnife Ablation Systems. A copy of this report featuring AngioDynamics, Inc. (NASDAQ: ANGO) is available at: www.BollingerReport.com/index.php?sm1=ANGO.
Bollinger Report is featuring Kensey Nash Corporation for its changing role within the healthcare industry. Kensey Nash Corporation is a medical device company primarily focused in the field of regenerative medicine, which is the application of devices, materials and other therapies to help repair damaged or diseased tissues. To download researches and analysis on Kensey Nash Corporation (NASDAQ: KNSY) we welcome investors to visit: www.BollingerReport.com/index.php?sm2=KNSY.
About Bollinger Report Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.
Contact: Martin Schwartz Email Contact www.BollingerReport.com
1 Year Kensey Nash Chart |
1 Month Kensey Nash Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions